Evaluating screening for long-term complications of cystic fibrosis-related diabetes

Cystic fibrosis-related diabetes (CFRD) differs from type 1 and type 2 diabetes, but has similar characteristics (Moran et al, 2010). As life expectancy has increased for people with cystic fibrosis (CF), CFRD and its inevitable complications are becoming more prevalent. The CF Trust (2004) guidelines suggest that all people with CFRD are screened annually for complications. This article reports on a screening programme for CFRD complications performed at a centre for adults with CF, where 38% of individuals have CFRD. The study demonstrates that annual screening for CFRD complications is important. A formal screening process should be adopted by all centres for adults with CF in an attempt to improve the care of this growing subgroup of people with CFRD.